Article Details
Retrieved on: 2021-04-16 18:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
We demonstrate the first stimulus-selective monoclonal antibodies targeting the transient receptor potential vanilloid 1 (TRPV1) channel, a clinically ...
Article found on: advances.sciencemag.org
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here